CDC Reports Which Patients Are Most Likely to Die From COVID-19
|
|
Patients diagnosed with COVID-19 often aren’t sure when they need to go to or return to the hospital, and pharmacists and other healthcare professionals are put in a difficult position when asked for guidance. A new CDC report should help: It discusses which patients are most likely to die from novel coronavirus infection and why some younger patients are more at risk than others. Here are the details.
|
|
Statins Continue to Have CV, Mortality Benefit in Patients Aged 75 Years and Older
|
|
Don’t be too quick to suggest that elderly patients need to go off some of their preventive medications. A new study advises that statins lower overall mortality in patients aged 75 years and older, as well as reduce specific cardiovascular (CV) deaths. Here is more information.
|
Reduced Dose of Prasugrel Shown to Be Safe, Effective for ACS Patients
|
|
Older age or lower weight can complicate treatment for acute coronary syndrome (ACS) patients. Find out how a new study examining the issue determined that a reduced dose of the antiplatelet prasugrel was as effective, and also was associated with a reduced risk of bleeding, when compared with a standard dose of tricagrelor.
|
|
Cream Containing PDE-4 Inhibitor Shows Promise for Psoriasis Patients
|
|
Systemic oral phosphodiesterase type 4 (PDE-4) inhibitors have made a big difference in how psoriasis is treated. But what about topical formulations? Find out the results of a study looking at the effectiveness and safety of roflumilast cream that contains a PDE-4 inhibitor in easing psoriasis symptoms.
|
|